Literature DB >> 19088443

Biophysical characterization of the short QT mutation hERG-N588K reveals a mixed gain-and loss-of-function.

Morten Grunnet1, Thomas G Diness, Rie Schultz Hansen, Soren-Peter Olesen.   

Abstract

The short QT syndrome is a newly discovered pro-arrhythmic condition, which may cause ventricular fibrillation and sudden death. Short QT can originate from the apparent gain-of-function mutation N588K in the hERG potassium channel that conducts repolarising I(Kr) current. The present study describes a profound biophysical characterization of HERG-N588K revealing both loss-of-function and gain-of-function properties of the mutant. Experiments were conducted after heterologous expression in both Xenopus laevis oocytes and mammalian cells and at both room temperature and at 37 degrees C. Also the impact of the beta-subunits KCNE2 was investigated. The most prominent loss-of-function property of HERG-N588K was reduced tail currents but also the activation properties was compromised. Based on these biophysical results we suggest that the general view of HERG-N588K being a gain-of-function is modified to a mixed gain- and loss-of-function mutation. This might also have impact on the pathological picture of the HERG-N588K channels ability to trigger arrhythmic events. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19088443     DOI: 10.1159/000185545

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  4 in total

1.  Molecular determinants of human ether-à-go-go-related gene 1 (hERG1) K+ channel activation by NS1643.

Authors:  Morten Grunnet; Jennifer Abbruzzese; Frank B Sachse; Michael C Sanguinetti
Journal:  Mol Pharmacol       Date:  2010-09-27       Impact factor: 4.436

Review 2.  The short QT syndrome.

Authors:  Brian Cross; Munther Homoud; Mark Link; Caroline Foote; Ann C Garlitski; Jonathan Weinstock; N A Mark Estes
Journal:  J Interv Card Electrophysiol       Date:  2011-04-14       Impact factor: 1.900

3.  In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.

Authors:  Cunjin Luo; Kuanquan Wang; Henggui Zhang
Journal:  PLoS One       Date:  2017-06-20       Impact factor: 3.240

4.  hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndrome.

Authors:  M J McPate; H Zhang; J M Cordeiro; C E Dempsey; H J Witchel; J C Hancox
Journal:  Biochem Biophys Res Commun       Date:  2009-06-06       Impact factor: 3.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.